Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
104.80    -2.40 (-2.24%)
Bid:
104.80
Ask:
106.00
Spread: 1.20 (1.145%)
Market Cap: £440.53m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Update on St. Tropez

26 Jun 2025 07:00

RNS Number : 4565O
PZ CUSSONS PLC
26 June 2025
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

26 June 2025

Update on St. Tropez sale and announcement of strategic partnership

 

In April 2024, PZ Cussons ("PZ Cussons" or "the Group") announced its intention to sell the St. Tropez brand, as part of a broader plan to refocus its portfolio. The Group has since run an extensive auction process which resulted in a number of offers being received. This has been against a backdrop of a challenging performance for the business, with a revenue decline in FY25 in the US and a wider contraction of valuation multiples across the Beauty category.

 

During the course of the process, the Board explored a number of alternative business models which could create more value for shareholders. As such, and after careful evaluation of the offers received, the Board has decided to retain St. Tropez and set a new strategic direction for the brand.

 

This will see us establish a focused team to lead the St. Tropez brand across the Group's international footprint. This team will be incentivised against the identified value drivers of the business: winning in-market execution including digital activation, re-igniting innovation and rejuvenating the brand's equity.

 

A critical component of the plan includes the formation of a strategic partnership with The Emerson Group ('Emerson'). Emerson is a leading, US-based partner to brand owners and will provide customer management, logistics services and brand activation in the US. St. Tropez will be integrated into Emerson's dedicated selling teams to key US retailers - an arrangement which builds on PZ Cussons' existing relationship with Emerson as the distributor of Childs Farm in the US. The Board is confident that this partnership will return St. Tropez to growth in the US, combining Emerson's distribution reach and brand activation capabilities, with the brand equity of St. Tropez. The move will help address the challenge of our sub-scale operations in the US, as identified previously, as well as further learnings gleaned over recent months. We look forward to strengthening retailer relationships as we work in partnership with Emerson to build the brand.

 

Reflecting the recent performance of St. Tropez, the Group expects to record a non-cash impairment with its FY25 results announcement in September. St. Tropez contributed £7.5 million of adjusted operating profit in FY25.

 

Further details regarding the future plans for St. Tropez will be provided in September.

 

Jonathan Myers, Chief Executive Officer, PZ Cussons said:

"Today we are setting a new direction for St. Tropez with a renewed operating model built around a focused and incentivised team, a re-set of our 'go to market' capabilities in the US and proven Group operations in our other markets. With these changes, we are confident in the future of the brand as part of the PZ Cussons portfolio."

 

Scott Emerson, Chief Executive Officer, Emerson Group said:

 

"We're thrilled to have the opportunity to work with the iconic St. Tropez brand and to expand our presence in the high-growth self-tanning category. This collaboration builds on the strong partnership we've established with PZ Cussons in the US, and we're excited to help bring the innovation and quality of St. Tropez to even more consumers across the market."

 Contact details

 

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

 

About PZ Cussons

 

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK. We employ just under 2,500 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St. Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKELFLEQLZBBZ
Date   Source Headline
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.